/ Print /

Hospitals & Providers Strategy

Robust multiple myeloma treatment program holds promiseThe Medical College of Wisconsin’s multiple myeloma program is robust and growing.
Innovative strategies help fight multiple myeloma: What every exec should knowAs new scientific advancements occur at the genetic and protein levels, more strategies have been developed to identify and combat multiple myeloma.
Five imitation-worthy palliative care programsHere's how five health plans are successfully approaching palliative care.
Diabetes prevention programs avert, delay disease onsetDiabetes accounts for one out of every 10 American healthcare dollars spent, but new national programs are helping address this issue.
Patients who need PCSK9 inhibitors cant get themStudy: PCSK9 inhibitors are being rejected by insurers at very high rates even in high-risk patients like those with familial hypercholesterolemia.
Opinion: Substance use disorder privacy law limits both payers, prescribersTwo University of Massachusetts Medical School pharmacists make the case to reform or align 42 CFR Part 2 with HIPAA to better serve patients with substance use disorder.
Here’s why preventive care should be a priorityA Cleveland Clinic study examines the mortality burden of modifiable behavioral risk factors such as obesity, diabetes, tobacco use, high blood pressure and high cholesterol.
Researchers identify more effective, cost-efficient test for breast cancer riskNew findings reveal this genetic test to assess breast cancer risk could be more effective than others.
ACA uncertainty impacts rate of insured: What health execs should knowA Gallup-Healthways poll shows it will be important to monitor the uninsured trends in the coming months as the ACA hangs in the balance.
Zika vaccine progress: Five things to knowTo date, the CDC reports 5,234 Zika virus disease cases in the United States and 36,526 cases in U.S. territories. Here’s where we are in the vaccine development process.